Morgan Stanley’s Cogent Biosciences COGT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.83M Sell
1,229,121
-46,574
-4% -$334K ﹤0.01% 3551
2025
Q1
$7.64M Buy
1,275,695
+317,066
+33% +$1.9M ﹤0.01% 3567
2024
Q4
$7.48M Buy
958,629
+269,735
+39% +$2.1M ﹤0.01% 3641
2024
Q3
$7.44M Sell
688,894
-292,750
-30% -$3.16M ﹤0.01% 3655
2024
Q2
$8.28M Sell
981,644
-869,072
-47% -$7.33M ﹤0.01% 3465
2024
Q1
$12.4M Sell
1,850,716
-2,667,686
-59% -$17.9M ﹤0.01% 3165
2023
Q4
$26.6M Buy
4,518,402
+4,388,903
+3,389% +$25.8M ﹤0.01% 3089
2023
Q3
$1.26M Sell
129,499
-42,676
-25% -$416K ﹤0.01% 4658
2023
Q2
$2.04M Sell
172,175
-75,495
-30% -$894K ﹤0.01% 4409
2023
Q1
$2.67M Sell
247,670
-243,767
-50% -$2.63M ﹤0.01% 4270
2022
Q4
$5.68M Sell
491,437
-73,682
-13% -$852K ﹤0.01% 3640
2022
Q3
$8.43M Buy
565,119
+287,972
+104% +$4.3M ﹤0.01% 3148
2022
Q2
$2.5M Buy
277,147
+260,126
+1,528% +$2.35M ﹤0.01% 4358
2022
Q1
$128K Sell
17,021
-769
-4% -$5.78K ﹤0.01% 6165
2021
Q4
$153K Buy
17,790
+9,622
+118% +$82.8K ﹤0.01% 6203
2021
Q3
$68K Buy
8,168
+478
+6% +$3.98K ﹤0.01% 6574
2021
Q2
$62K Sell
7,690
-57,467
-88% -$463K ﹤0.01% 6573
2021
Q1
$572K Sell
65,157
-864,304
-93% -$7.59M ﹤0.01% 5078
2020
Q4
$10.4M Buy
929,461
+917,797
+7,869% +$10.3M ﹤0.01% 2465
2020
Q3
$109K Buy
11,664
+8,808
+308% +$82.3K ﹤0.01% 5389
2020
Q2
$5K Sell
2,856
-1,863
-39% -$3.26K ﹤0.01% 6292
2020
Q1
$8K Sell
4,719
-22,322
-83% -$37.8K ﹤0.01% 6068
2019
Q4
$78K Sell
27,041
-2,165
-7% -$6.25K ﹤0.01% 5728
2019
Q3
$169K Buy
29,206
+18,412
+171% +$107K ﹤0.01% 5220
2019
Q2
$113K Sell
10,794
-5,549
-34% -$58.1K ﹤0.01% 5267
2019
Q1
$288K Sell
16,343
-5,805
-26% -$102K ﹤0.01% 4868
2018
Q4
$390K Buy
22,148
+17,091
+338% +$301K ﹤0.01% 4948
2018
Q3
$208K Sell
5,057
-1,227
-20% -$50.5K ﹤0.01% 5443
2018
Q2
$361K Sell
6,284
-46,959
-88% -$2.7M ﹤0.01% 5284
2018
Q1
$2.37M Buy
+53,243
New +$2.37M ﹤0.01% 3840